Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Clifford Chance says it is advising Luxinva on the proposed QIAGEN takeover
Clifford Chance said it is advising Luxinva, an Abu Dhabi Investment Authority subsidiary, as an indirect co-investor in the proposed takeover of QIAGEN alongside EQT Private Equity and CPP Investments. The firm said the all-cash offer values QIAGEN at approximately €10.8 billion including net debt.
Key points
- The firm said the offer price is €46.50 per share.Clifford Chance
- Clifford Chance said that represents an approximately 40.3% premium to the unaffected share price.Clifford Chance
- The firm said completion remains subject to conditions in the combination agreement and offer document.Clifford Chance
- Clifford Chance identified Thomas Krecek, Christian Vogel, Dominik Heß and Samuel Frommelt among its corporate partners on the matter.Clifford Chance